Related Experiment Video
Updated: Aug 6, 2026

Deciphering the Molecular Mechanism and Function of Pore-Forming Toxins Using Leishmania major
Published on: October 28, 2022
Drug resistance in Leishmania: similarities and differences to other organisms
B Papadopoulou1, C Kündig, A Singh
1Centre de Recherche en Infectiologie du Centre de Recherche du CHUL et Départment de Biologie Médicale, Division de Microbiologie, Faculté de Médecine, Université Laval, Québec, Canada GIV 4G2. Barbara.Papadopoulou@crchul.ulaval.ca
Abstract:
The main line of defense available against parasitic protozoa is chemotherapy. Drug resistance has emerged however, as a primary obstacle to the successful treatment and control of parasitic diseases. Leishmania spp., the causative agents of leishmaniasis, have served as a useful model for studying mechanisms of drug resistance in vitro. Antimonials and amphotericin B are the first line drugs to treat Leishmania followed by pentamidine and a number of other drugs. Parasites resistant against all these classes of drugs have been selected under laboratory conditions. A multiplicity of resistance mechanisms has been detected, the most prevalent being gene amplification and transport mutations. With the tools now available, it should be possible to elucidate the mechanisms that govern drug resistance in field isolates and develop more effective chemotherapeutic agents.
Related Concept Videos
Antiprotozoal Agents
Leishmaniasis
Development of Antibiotic Resistance
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Malaria
Treatment Resistant Cancers

